Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE: Dropizol for severe cancer treatment-induced diarrhoea
ISRCTN71510134Phase 4Terminated
- Sponsor
- Atnahs
- Start
- May 2025
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 4, randomised, open-label trial of opium tincture and loperamide in diarrhea (3 arms), sponsored by Atnahs. Primary endpoint: Primary efficacy endpoint. Started May 2025; status: terminated.
02
Drugs
opium tinctureloperamide
03
Conditions
diarrhea
Beyond the preview
Go deeper on ISRCTN71510134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN71510134.